Pro Medicus Limited (PMCUF) Receives a Sell from Citi
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 13 2025
0mins
Source: Business Insider
Analyst Rating and Price Target: Citi analyst Mathieu Chevrier maintains a Sell rating on Pro Medicus Limited with a price target of A$165.00, while the stock closed at $178.00, amidst a general Hold consensus from analysts with an average price target of $164.00.
Financial Performance and Insider Activity: Pro Medicus reported strong quarterly earnings with revenue of $87.39 million and a net profit of $46.54 million, but insider sentiment is negative as there has been an increase in insiders selling shares compared to earlier this year.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
